Search for dissertations about: "proton pump inhibitors"
Showing result 1 - 5 of 25 swedish dissertations containing the words proton pump inhibitors.
-
1. Proton pump inhibitors: indications and acid rebound
Abstract : Proton pump inhibitors (PPIs) are nowadays the therapy of choice in the management of a variety of upper gastrointestinal (GI) conditions particularly gastroesophageal reflux disease (GERD). Previous studies indicate that patients commonly receive PPIs without clear indications. READ MORE
-
2. Pharmacodynamic Modelling of Irreversible and Reversible Gastric Proton Pump Inhibitors
Abstract : Acid related diseases like GERD, duodenal-and gastric ulcers and H. Pylori-positive peptic ulcer disease are primarily managed by reducing gastric acidity. Irreversible proton pump inhibitors (PPIs) inhibit gastric acid secretion effectively throughout the day by irreversibly inhibiting the gastric proton pump, H+, K+-ATPase, in the parietal cells. READ MORE
-
3. Perforations of the Upper Gastro-Intestinal Tract
Abstract : Material and methods: In all, 237 consecutive patients with a perforated peptic ulcer admitted from 1974-1992 and 125 consecutive patients with an oesophageal perforation admitted from 1970-2006 to Lund University hospital were studied retrospectively. Prognostic factors were evaluated using the Cox proportional hazards model. READ MORE
-
4. Infections Related to the Use of Medical Devices and Changes in the Oropharyngeal Flora
Abstract : Background: Humans exist in mutualistic balance with a large range of microbiota. Illness and hospitalization can disturb this balance and contribute to hospital-acquired infections (HAIs), which occur most often in critically ill patients. READ MORE
-
5. Faecal Calprotectin Diagnostics : Focus on Primary Care and Suspected Sources of Error
Abstract : Patients with gastrointestinal symptoms often present a diagnostic challenge for general practitioners. Faecal calprotectin (FC) is commonly used as a marker of intestinal inflammation and is useful for differentiating between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as for the follow-up of patients with IBD and monitoring treatment response. READ MORE
